Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy

OBJECTIVE: To assess safety and efficacy of deflazacort (DFZ) and prednisone (PRED) vs placebo in Duchenne muscular dystrophy (DMD). METHODS: This phase III, double-blind, randomized, placebo-controlled, multicenter study evaluated muscle strength among 196 boys aged 5–15 years with DMD during a 52-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurology
Autors principals: Griggs, Robert C., Miller, J. Phillip, Greenberg, Cheryl R., Fehlings, Darcy L., Pestronk, Alan, Mendell, Jerry R., Moxley, Richard T., King, Wendy, Kissel, John T., Cwik, Valerie, Vanasse, Michel, Florence, Julaine M., Pandya, Shree, Dubow, Jordan S., Meyer, James M.
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5109941/
https://ncbi.nlm.nih.gov/pubmed/27566742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000003217
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars